Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Calzado Lopez (MADRID, Spain), C. Gotera Rivera (MADRID, Spain), T. Pérez Warnisher (MADRID, Spain), R. Melchor Iñiguez (MADRID, Spain), J. Pinillos Robles (MADRID, Spain), E. Cabezas Pastor (MADRID, Spain), A. El Hachem Debek (MADRID, Spain), M. Rodríguez Guzmán (MADRID, Spain), P. Lazo Meneses (MADRID, Spain), J. Alfayate Sánchez (MADRID, Spain), N. González Mangado (MADRID, Spain), G. Peces Barba (MADRID, Spain), L. Seijo Maceiras (MADRID, Spain). Prevalence and characterization of interstitial lung disease in a lung cancer screening program. 1324

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and burden of bronchiectasis in a lung cancer screening program Source: International Congress 2019 – Airway infection in COPD Year: 2019 Prevalence of bronchiectasis in a lung cancer screnning program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Interstitial lung diseases in a lung cancer screening trial Source: Eur Respir J 2011; 38: 392-400 Year: 2011 Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 The Asian experience in co-existing lung cancer and interstitial lung disease Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017 Prior lung disease and risk of lung cancer in women Source: Eur Respir J 2005; 26: Suppl. 49, 598s Year: 2005 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Pulmonary function testing in patients with lung cancer Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Prevalence and clinical characteristics of lung cancer with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020